22
Basic
Limited
Enhanced
Best supportive
care
Systemic/Palliative Treatment for Recurrent
Ovarian Cancer
Clinicians may
recommend
treatment with
second-line
chemotherapy
to patients with
platinum-sensitive
and platinum-
resistant/platinum-
refractory ovarian
cancer OR refer to
higher-level cancer
center
Clinicians may
recommend
treatment with
second-line
chemotherapy
to patients with
platinum-sensitive
and platinum-
resistant/platinum-
refractory ovarian
cancer
Figure 5. Recurrent Ovarian Cancer Recommendations by
Resource Level (cont'd)
Combination
chemotherapy
with carboplatin
preferably for
patients with
platinum-sensitive
recurrent ovarian
cancer OR refer to
higher-level cancer
center
Combination
chemotherapy
with carboplatin
preferably for
patients with
platinum-sensitive
recurrent ovarian
cancer
Single-agent
non-platinum
chemotherapy or
best supportive
care for patients
with platinum-
resistant/platinum-
refractory
recurrent ovarian
cancer OR refer to
higher level cancer
center
Single-agent
non-platinum
chemotherapy ±
bevacizumab or
best supportive
for patients with
platinum-resistant
recurrent ovarian
cancer
a
Due to current gaps in health system and human resource availability.
Treatment for Recurrent Cancer
